
The Ghana Association of Medical Laboratory Scientists (GAMLS) has called on the government to significantly increase investment in laboratory diagnostics to ensure the success of the Free Primary Healthcare Programme. Speaking at a recent forum, GAMLS President Dr. Eric Kofi Aidoo emphasized that the expansion of healthcare access must be matched by a robust diagnostic framework to provide accurate and timely medical interventions for Ghanaians. The association argued that as the state works to remove financial barriers to care, the technical capacity to identify ailments must be prioritized to avoid a breakdown in service quality.
According to the association, the effective implementation of free primary healthcare depends on three critical pillars: adequate funding, modern equipment, and highly skilled personnel. Dr. Robert Amesiya, a key speaker at the event, highlighted that laboratory services are the backbone of early disease detection and management. He noted that without reliable diagnostic data, the quality of care provided under the national programme could be compromised, potentially leading to misdiagnosis or delayed treatment, which would ultimately increase the burden on the healthcare system.
The association also identified several systemic challenges currently hindering the sector, including frequent reagent shortages and the presence of inadequately trained staff in some facilities. To address these issues and ensure professional standards are upheld, GAMLS reiterated its call for the establishment of a Medical Laboratory Council. This regulatory body would be responsible for overseeing the practice, ensuring that only qualified professionals operate within the diagnostic space, and maintaining the integrity of laboratory results across the country.
The Free Primary Healthcare Programme remains a cornerstone of the current administration's strategy to improve national health outcomes. However, GAMLS maintains that for this vision to be fully realized, the government must look beyond consultation and treatment to the underlying diagnostic infrastructure. By investing in the laboratory value chain, the association believes the state can reduce the overall cost of healthcare through more efficient disease management and better patient outcomes, securing the long-term sustainability of the free healthcare initiative.